|
TTF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.238700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.003970E-01 |
| Normal-vs-Stage2 |
3.246500E-02 |
| Normal-vs-Stage3 |
5.961900E-02 |
| Normal-vs-Stage4 |
6.905000E-01 |
| Stage1-vs-Stage2 |
3.538800E-01 |
| Stage1-vs-Stage3 |
3.174400E-01 |
| Stage1-vs-Stage4 |
6.437800E-01 |
| Stage2-vs-Stage3 |
9.791800E-01 |
| Stage2-vs-Stage4 |
2.256400E-01 |
| Stage3-vs-Stage4 |
1.921820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.369900E-02 |
| Normal-vs-AfricanAmerican |
1.465960E-01 |
| Normal-vs-Asian |
1.106760E-01 |
| Caucasian-vs-AfricanAmerican |
7.807800E-01 |
| Caucasian-vs-Asian |
1.965400E-01 |
| AfricanAmerican-vs-Asian |
2.016000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.704240E-01 |
| Normal-vs-Female |
1.772270E-04 |
| Male-vs-Female |
9.805900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.440640E-01 |
| Normal-vs-Extreme_Weight |
6.984800E-01 |
| Normal-vs-Obese |
6.092000E-02 |
| Normal-vs-Extreme_Obese |
4.485200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.240800E-01 |
| Normal_Weight-vs-Obese |
9.733600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.731000E-01 |
| Extreme_Weight-vs-Obese |
1.135180E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.339400E-01 |
| Obese-vs-Extreme_Obese |
8.544200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.642290E-02 |
| Normal-vs-Age(41-60Yrs) |
4.656700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.418440E-01 |
| Normal-vs-Age(81-100Yrs) |
3.754800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.027800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.378200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.075100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.164960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.856300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.665900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.948160E-01 |
| Normal-VS-Type2 PRCC |
3.796300E-02 |
| Normal-VS-KIRP CIMP |
5.931800E-02 |
| Normal-VS-Unclassified PRCC |
5.039500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.771850E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.178400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.295700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.151200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.130000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.827000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.476000E-01 |
| Normal-vs-N1 |
2.190400E-02 |
| Normal-vs-N2 |
5.876400E-01 |
| N0-vs-N1 |
6.276000E-02 |
| N0-vs-N2 |
6.621000E-01 |
| N1-vs-N2 |
9.784200E-01 |
|
|
